Cases 1 - 10 of 76
In re: Mylan Inc. et al
as 1:2022mc00501
Petitioner:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Respondent:
Somaxon Pharmaceuticals Inc., Procom One Inc., Currax Pharmaceuticals LLC and others
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv01228
Plaintiff:
Bayer Pharma AG and Bayer AG
Counter Defendant:
Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Counter Claimant:
Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Somaxon Pharmaceuticals Inc
as 1:2022mc00275
Respondent:
Somaxon Pharmaceuticals Inc., Currax Pharmaceuticals LLC, Currax Holdings LLC and others
Petitioner:
Mylan Inc. and Mylan Pharmaceuticals Inc.
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Bausch Health Ireland Limited et al v. Mylan Laboratories Ltd. et al
as 1:2021cv00611
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Agila Specialties Inc., Mylan Pharmaceuticals Inc., Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 1
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv01395
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00445
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00752
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
